FoodKefir maker Lifeway rejects Danone’s second takeover offer

Kefir maker Lifeway rejects Danone’s second takeover offer

-

spot_img


This audio is auto-generated. Please let us know if you have feedback.

Lifeway Foods rejected an increased offer from Danone, with the kefir products maker saying the latest proposal “substantially undervalues” its business. 

Dairy giant Danone last week increased its offer to buy the remaining stock it doesn’t already own in Lifeway to about $307 million, or $27 a share, up from an earlier $283 million, or $25 a share, proposal in September. Danone currently owns 23.3% of Lifeway’s common shares.

“The Company plans to continue to build on its strong momentum to unlock additional shareholder value,” Lifeway said in a statement. “The Board and management are committed to acting in the best interests of all shareholders and ensuring that they are able to realize the full potential value of their investment.”

Lifeway noted that it “remains focused on executing its strategic plan to bring kefir to more households while also expanding into adjacent categories. Earlier on Wednesday, Lifeway introduced its latest functional beverage innovation: Probiotic Smoothie + Collagen made with kefir cultures.

In rebuffing Danone, Lifeway noted its recent success. The Illinois-based company highlighted that it has posted 20 consecutive quarters of growth and posted a double-digit year-over-year revenue increase.

Lifeway, a major beneficiary of increasing consumer demand for healthier products would complement Danone’s portfolio of better-for-you offerings. Danone owns brands such as probiotic-focused Activia and low-sugar Too Good yogurts.

Danone declined to comment on Lifeway’s rejection of its second proposal.

In a letter sent to Lifeway last week, Danone said that the $27 offer “represents a compelling proposition to [its] shareholders and reflects the fundamental potential of the Company.” It also pointed out that a purchase would remove expenses tied to being a public company and unlock value for Lifeway by increasing innovation, distribution and marketing support.



Source link

Latest news

On Its Longevity Quest, LVMH’s R&D Teams With Integrated Biosciences

PARIS – As part of its quest for longevity, LVMH Moët Hennessy Louis Vuitton’s research-and-development division and Integrated Biosciences...

Romania and Bulgaria to join EU’s Schengen free movement area

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly...

Addressing inequities in cardiovascular drug access

A new study assessing provincial and...

Ganni Pre-Fall 2025 Collection | Vogue

It’s been a banner year for Ganni, which presented its spring 2025 collection in Paris. This wasn’t a...
spot_img

Conservative US commentator Candace Owens granted NZ visa after government intervention | New Zealand

The controversial US commentator Candace Owens has been granted a visa to enter New Zealand after the government...

Understanding how angiogenesis contributes to drug resistance in breast cancer

Breast cancer, the most common cancer...

Must read

On Its Longevity Quest, LVMH’s R&D Teams With Integrated Biosciences

PARIS – As part of its quest for longevity,...

Romania and Bulgaria to join EU’s Schengen free movement area

Unlock the Editor’s Digest for freeRoula Khalaf, Editor...
spot_img

You might also likeRELATED
Recommended to you